For the first time, UAE produces local immune cell therapy using the "CAR T-cell" technology

The Abu Dhabi Stem Cell Center - a specialized research institute in Abu Dhabi - has launched the first trial of its kind in the UAE and the region to study the efficacy and safety of immune cell therapy known as T-cells using CAR T-cell receptors in the treatment of blood cancers such as myeloma, lymphoma and certain types. from leukemia.

Immune cell therapy using CAR T-cell receptors is a globally recognized new technology for immunotherapies, which employs the body's defense system by reprogramming immune cells, which are an essential component of the body's anti-tumor response mechanism, preparing them to perform With the tasks of searching for and eliminating cancer, these programmed cells become a living drug that travels through the body and uses the immune system constantly to attack the disease

The establishment of the Abu Dhabi Stem Cell Center, the first of its kind in the UAE, came in 2019, with the aim of meeting the growing local and regional demand for the most advanced and innovative medical services and treatments in the country. It focuses its efforts on providing the latest research on stem cells in the region according to the highest quality standards and the best Patient satisfaction levels at every step of the care journey.